Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00213733
Status:
COMPLETED
Last Update Posted:
2011-08-30
First Post:
2005-09-13
Brief Title:
Molecular Assessment of Lymph Nodes in Patients With Resected Stage I to IIIA Non-small Cell Lung Cancer
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Research of Molecular Markers for Diagnosis andor Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer
Status:
COMPLETED
Status Verified Date:
2011-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective study of surgically resected samples and lymph nodes of lung cancer patients For histopathologically positive lymph nodes from a complete resection the investigators would like to analyse tumor tissue by allelotyping and comparing these results with those observed in the primary lung tumor to establish a cartography of molecular alteration in resected lung cancer For non histopathologically positive lymph nodes the investigators would like to research the presence or not of micrometastasis by allele-specific PCR polymerase chain reaction
Detailed Description:
Genetic It is a prospective study during two years with three years for follow-up No control group is recruited
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None